Intraosseous devices help inject the fluid directly in the bone marrow of a bone in the body. This process offers a non-collapsible entry point in the systemic venous system. Besides fluids, these devices also transfer medications in cases when intravenous access is not feasible or available. Intraosseous devices enable the injected medications to go directly in the vascular systems. Different methods of injecting or inserting fluids in the body are intramuscular (IM), intravenous (IV), and intraosseous (IO), which are based on the route of administration. Among these, intraosseous route of administration is superior to intramuscular and similar to intravenous, especially for delivering pediatric drugs. These infusions are done in traumatic patients when they have compromised intravenous methods and require quick delivery of life saving medication and fluids.
The European Resuscitation Council (ERC) and American Heart Association (AHA) recommend the usage of intraosseous access during CPR if there's no possibility to instantly achieve peripheral vein access. Most of the intraosseous devices are successfully placed within less than a minute from the time of opening the package to using the device to administer the medication. Correct placement is confirmed by flow of intravenous fluid or medication into the device without any extravasation of the medication around the insertion site. Increase in the instances of emergency situations has prompted the key players in this market to work towards launching intraosseous devices that are technologically advanced, user friendly, have value added features, there by spur the growth of this market.Major Key Players of the Intraosseous Devices Market are:
Teleflex Incorporated, PERSYS MEDICAL, Cook, BD, and Biopsybell, among others.
No comments:
Post a Comment